Shares of Kinaxis Inc. (OTCMKTS:KXSCF – Get Rating) have been assigned a consensus recommendation of “Buy” from the eight research firms that are currently covering the stock, Marketbeat.com reports. Four research analysts have rated the stock with a buy rating. The average 12-month price target among brokers that have issued a report on the stock in the last year is $215.38.
A number of equities analysts have recently weighed in on KXSCF shares. Stifel Nicolaus cut their target price on Kinaxis from C$235.00 to C$215.00 in a research note on Thursday, March 3rd. Royal Bank of Canada dropped their price objective on Kinaxis from C$225.00 to C$200.00 in a research note on Thursday, March 3rd. Canaccord Genuity Group dropped their price objective on Kinaxis from C$225.00 to C$200.00 in a research note on Thursday, March 3rd. Finally, Scotiabank lowered their target price on shares of Kinaxis from C$213.00 to C$208.00 in a report on Thursday, March 3rd.
Shares of KXSCF opened at $116.50 on Friday. Kinaxis has a one year low of $107.40 and a one year high of $180.40. The stock has a 50-day moving average of $124.51 and a 200-day moving average of $137.36.
Kinaxis, Inc engages in the provision of cloud-based subscription software. Its solutions include sales and operations, capacity, demand inventory, machine learning, and supply planning. The company was founded by Duncan Klett in 1984 and is headquartered in Ottawa, Canada.
See Also
- Get a free copy of the StockNews.com research report on Kinaxis (KXSCF)
- Institutions And Analysts Drive UnitedHealth Group Higher
- MarketBeat: Week in Review 4/11 – 4/15
- Three Beaten Down Mega Caps The Analysts Are Upgrading
- Top 3 Safe Stocks for Conservative Investors
- UiPath Stock is Nearing Rock Bottom Down Here
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.